K093177 · Philips Medical Systems · MWI · Dec 18, 2009 · Cardiovascular
Device Facts
Record ID
K093177
Device Name
INTELLIBRIDGE SYSTEM
Applicant
Philips Medical Systems
Product Code
MWI · Cardiovascular
Decision Date
Dec 18, 2009
Decision
SESE
Submission Type
Special
Regulation
21 CFR 870.2300
Device Class
Class 2
Intended Use
The IntelliBridge System is indicated for use in the data collection and clinical information management either directly or through networks with independent bedside devices. The IntelliBridge System is not intended for monitoring purposes nor is the device intended to control any of the clinical devices (independent bedside devices / information systems) it is connected to.
Device Story
IntelliBridge System functions as a data management system for clinical information; collects data from independent bedside devices via network or direct connection. System components include EC40/EC80 multi-port modules and SC50 management console. Device does not perform patient monitoring or control connected bedside equipment; serves as a conduit for data aggregation and management. Used in clinical environments; operated by healthcare professionals. Output allows clinicians to view aggregated data from various bedside devices to support clinical information management workflows.
Clinical Evidence
Bench testing only. Verification and validation activities included system-level tests, performance tests, and hazard analysis. Pass/Fail criteria based on predicate device specifications; results confirmed performance and reliability requirements were met.
Technological Characteristics
Data management system comprising EC40/EC80 multi-port modules and SC50 management console. Connectivity via network or direct interface to bedside devices. Software-based transmission and storage of patient data. No patient monitoring or alarm functionality.
Indications for Use
Indicated for data collection and clinical information management from independent bedside devices. Not intended for patient monitoring or control of connected clinical devices.
Regulatory Classification
Identification
A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.
Predicate Devices
Philips DeviceLink System
Related Devices
K041401 — MODIFICATION TO M2376A DEVICELINK SYSTEM · Philips Medical Systems · Jun 4, 2004
K022920 — M2376A DEVICELINK SYSTEM · Philips Medical Systems · Sep 17, 2002
K033283 — CENTRA VIEW DEVICE LINK SYSTEM · Icu Datasystems, Inc. · Oct 27, 2003
K020494 — MODIFICATION TO M2376A DEVICELINK SYSTEM · Philips Medical Systems, Inc. · Feb 21, 2002
K033680 — M2376A PHILIPS DEVICE LINK SYSTEM · Philips Medical Systems · Dec 11, 2003
Submission Summary (Full Text)
{0}------------------------------------------------
K093177 pg 1 of 1
## 510K Summary
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 CFR 807-92(c).
- The submitter of this pre-market notification is: 1. Claire Arakaki Philips Medical Systems 3000 Minuteman Road Andover, MA 01810 United States Tel: 978-659-4348 Fax: 978-685-5624 Email: Claire.arakaki@philips.com
DEC 1 8 2009
This summary was prepared on September 25, 2009.
- The name of the subject device is the Philips IntelliBridge System. 2.
- 3. The trade name of the device is the Philips IntelliBridge System.
- The common usual name is data management system. 4.
- The Classification names are as follows: న్.
| Device Panel | Classification | ProCode | Description |
|------------------|----------------|---------|-----------------------------------------------------------------------------|
| General Hospital | Not classified | NSX | Software, transmission and storage, patient<br>data |
| Cardiovascular | 870.2300, II | MWI | Monitor, Physiological, Patient (without<br>arrhythmia detection or alarms) |
| Cardiovascular | 870.1025, II | MHX | Monitor, Physiological, Patient (with<br>arrhythmia detection or alarms) |
- The modified device is substantially equivalent to the previously cleared Philips DeviceLink System. ર.
- The major modifications are as follows: 7.
- Introduction of a new multi-port module (EC40/EC80) ♥
- Introduction of a management console (SC50) .
- The subject device has the same intended use as the legally marketed predicate device: 8. The IntelliBridge System is indicated for use in the data collection and clinical information management either directly or through networks with independent bedside devices. The IntelliBridge System is not intended for monitoring purposes nor is the device intended to control any of the clinical devices (independent bedside devices / information systems) it is connected to.
- The subject device has the same fundamental technological characteristics as the legally marketed 9. predicate devices.
- 10. Verification, validation, and testing activities establish the performance, functionality, and reliability characteristics of the subject devices with respect to the predicates. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Pass/Fail criteria were based on the specifications cleared for the predicate device, the specifications of the subject device and test results showed substantial equivalence. The results demonstrate that the Philips IntelliBridge System meets all reliability requirements and performance claims and supports a determination of substantial equivalence.
{1}------------------------------------------------
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized human figures.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
Philips Medical Systems c/o Claire Arakaki, Regulatory Affairs Specialist 3000 Minuteman Road Andover, MA 01810
DEC 1 8 2009
Re: K093177
Trade/Device Name: IntelliBridge System Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (including cardiotachometer and rate alarm) Regulatory Class: Class II Product Code: MWI Dated: November 25, 2009 Received: November 27, 2009
Dear Ms. Arakaki:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
{2}------------------------------------------------
Page 2 - Ms. Claire Arakaki
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours
Sincerely yours
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
pg loti
Indications for Use
510 (k) Number (if known): K093177
Device Name: IntelliBridge System
The IntelliBridge System is indicated for use in the data collection and clinical information management. The IntelliBridge System is not intended for monitoring purposes nor is the device intended to control any of the clinical devices (independent bedside devices / information systems) it is connected to.
YES AND/OR over-the-counter Use: NO Prescription Use: (Part 21 CFFR 801 Subpart D) (21 CFR 807 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Cardiovascular Devices 5) 01ki Numb
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.